التفاصيل البيبلوغرافية
| العنوان: |
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program |
| المؤلفون: |
Rebuzzi, S.E., Signori, A., Buti, S., Banna, G.L., Murianni, V., Damassi, A., Maruzzo, M., Giannarelli, D., Tortora, G., Galli, L., Rizzo, M., De Giorgi, U., Antonuzzo, L., Bracarda, S., Cartenì, G., Atzori, F., Tamberi, S., Procopio, G., Fratino, L., Lo Re, G., Santoni, M., Baldessari, C., Astone, A., Calabrò, F., Brunelli, M., Porta, C., Rescigno, P., Basso, U., Fornarini, G. |
| المصدر: |
ESMO Open ; volume 7, issue 6, page 100634 ; ISSN 2059-7029 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2022 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/j.esmoop.2022.100634 |
| الإتاحة: |
https://doi.org/10.1016/j.esmoop.2022.100634Test
https://api.elsevier.com/content/article/PII:S205970292200268X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S205970292200268X?httpAccept=text/plainTest |
| حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: |
edsbas.1F8C0816 |
| قاعدة البيانات: |
BASE |
